Practical Geriatrics ›› 2026, Vol. 40 ›› Issue (8): 837-842.doi: 10.3969/j.issn.1003-9198.2026.08.016

Previous Articles     Next Articles

Clinical characteristics and prognostic analysis of late-onset connective tissue disease-associated pulmonary arterial hypertension

XU Jie, ZHANG Yixin, ZHANG Miaojia, WANG Qiang, SUN Xiaoxuan   

  1. Department of Rheumatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029,China(XU Jie, ZHANG Miaojia, WANG Qiang, SUN Xiaoxuan);
    the First Clinical Medical College of Nanjing Medical University, Nanjing 210029, China(ZHANG Yixin)
  • Received:2026-02-06 Online:2026-08-20 Published:2026-08-24
  • Contact: SUN Xiaoxuan, Email:drsunxiaoxuan@163.com

Abstract: Objective To explore the clinical characteristics and risk factors for poor prognosis in patients with late-onset connective tissue disease (CTD) associated pulmonary arterial hypertension (PAH). Methods A retrospective analysis was conducted on patients diagnosed with CTD-PAH at Department of Rheumatology, the First Affiliated Hospital of Nanjing Medical University from January 2019 to December 2023 using right heart catheterization(RHC). Patients were divided into two groups: early-onset group(onset age<60 years) and late-onset group(onset age ≥60 years). Demographic data, cardiovascular risk factors (hypertension, coronary artery disease and diabetes), echocardiographic and RHC parameters, treatment for CTD and PAH, clinical failure-free survival rates were observed and compared between the two groups. And the influecing factors for clinical failve events was analysized. Results Compared with the early-onset group, the late-onset group had a higher prevalence of coronary heart disease and hypertension; Late-onset patients exhibited worse cardiac function, with a higher proportion of cardiac function grading Ⅲ-Ⅳ and significantly shorter 6-minute walk distance (6MWD) (P<0.05). Two-dimensional echocardiography showed that left atrial diameter (LAD), left ventricular end-diastolic diameter (LVDd), and the E/e′ ratio were significantly increased in the late-onset group than those in the early-onset group(P<0.05). Compared with the early-onset group, the utilization rate of glucocorticoids and the rate of combination targeted therapy for PAH were significantly lower in the late-onset group(P<0.05). Within one year of follow-up, the proportion of patients achieving a low-risk status in the late-onset group was significantly lower than that in the early-onset group (25.0% vs 62.1%,P<0.05). Cox regression analysis indicated that the E/e′ ratio was a risk factor for clinical failure events in patients with late-onset CTD-PAH(HR=1.295,95%CI:1.039-1.615,P=0.022). Conclusions Late-onset CTD-PAH patients have a higher incidence of cardiovascular risk factors, with elevated left atrial pressure and impaired left ventricular diastolic function. They generally have a poorer prognosis, and E/e′ is a risk factor for adverse outcomes in these patients.    

Key words: late-onset, connective tissue disease, pulmonary arterial hypertension, clinical characteristics, prognosis

CLC Number: